2025-05-01 2026-04-30 false No description of principal activity Acting Office - Tax and Accounts 1.0 05590505 bus:FullAccounts 2025-05-01 2026-04-30 05590505 bus:Micro-entities 2025-05-01 2026-04-30 05590505 bus:AuditExempt-NoAccountantsReport 2025-05-01 2026-04-30 05590505 bus:SmallCompaniesRegimeForAccounts 2025-05-01 2026-04-30 05590505 bus:PrivateLimitedCompanyLtd 2025-05-01 2026-04-30 05590505 2025-05-01 2026-04-30 05590505 2026-04-30 05590505 bus:RegisteredOffice 2025-05-01 2026-04-30 05590505 core:WithinOneYear 2026-04-30 05590505 core:AfterOneYear 2026-04-30 05590505 2024-05-01 05590505 bus:Director1 2025-05-01 2026-04-30 05590505 bus:Director1 2026-04-30 05590505 bus:Director1 2024-05-01 2025-04-30 05590505 bus:CompanySecretary1 2025-05-01 2026-04-30 05590505 bus:LeadAgentIfApplicable 2025-05-01 2026-04-30 05590505 2024-05-01 2025-04-30 05590505 2025-04-30 05590505 core:WithinOneYear 2025-04-30 05590505 core:AfterOneYear 2025-04-30 05590505 bus:EntityAccountantsOrAuditors 2024-05-01 2025-04-30 05590505 core:FurnitureFittings 2025-05-01 2026-04-30 05590505 core:FurnitureFittings 2026-04-30 05590505 core:FurnitureFittings 2025-04-30 05590505 core:ComputerEquipment 2025-05-01 2026-04-30 05590505 core:ComputerEquipment 2026-04-30 05590505 core:ComputerEquipment 2025-04-30 05590505 core:OtherPropertyPlantEquipment 2025-05-01 2026-04-30 05590505 core:OtherPropertyPlantEquipment 2026-04-30 05590505 core:OtherPropertyPlantEquipment 2025-04-30 05590505 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2026-04-30 05590505 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-04-30 05590505 core:Goodwill 2025-05-01 2026-04-30 05590505 core:Goodwill 2026-04-30 05590505 core:Goodwill 2025-04-30 05590505 core:CostValuation core:Non-currentFinancialInstruments 2026-04-30 05590505 core:CostValuation core:Non-currentFinancialInstruments 2025-04-30 05590505 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-04-30 05590505 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-04-30 05590505 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-04-30 05590505 core:ShareProfitOrLossIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-04-30 05590505 core:ProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-04-30 05590505 core:ImpairmentReversalProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-04-30 05590505 core:ForeignExchangeDifferencesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-04-30 05590505 core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-04-30 05590505 core:TransfersBetweenInvestmentClassesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-04-30 05590505 core:Non-currentFinancialInstruments 2026-04-30 05590505 core:Non-currentFinancialInstruments 2025-04-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 05590505
England and Wales

 

 

 


Unaudited Financial Statements

for the year ended 30 April 2026

for

LONDON CLINICAL RESEARCH LTD

 
 
 
£
2026
£
   
£
2025
£
Fixed assets 5,274  2,808 
Current assets 28,083  116,121 
Creditors: amount falling due within one year (4,723)
Net current assets/(liabilities) 23,360  116,121 
Total assets less current liabilities 28,634  118,929 
Net assets/(liabilities) 28,634  118,929 
 
Capital and reserves 28,634  118,929 
 
  1. For the year ended 30 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
  2. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Signed on behalf of the board of directors:


---------------------------------------------
Jessica Ruth Colman
Director

Date approved: 08 July 2026
1
Statutory Information
London Clinical Research Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number 05590505, registration address 16 Christopher Avenue, London, W7 2BN.

The presentation currency is £ sterling.
1.

Accounting Policies

Basis of accounting
The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
2.

Average number of employees

Average number of employees during the year was 1 (2025: 1).
2